Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma

Figure 7

Spearman correlation between risk score and immune checkpoints for tumor-targeted treatment. (a) CTLA-4. (b) VTCN1. (c) TNFSF18. (d) TNFSF15. (e) TNFSF14. (f) TNFRSF25. (g) TNFRSF9. (h) TNFRSF8. (i) TMIGD2. (j) CD276. (k) PDCD1LG2 (PD-L2). (l) PDCD1 (PD1). (m) LAIR1. (n) LAG3. (o) HAVCR2 (TIM3).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)